Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy
/in Dendritic Cells, International Publications /von 2015-10-01 / Pharmacol. Rev. 2015 Oct;67(4):731-53Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2015-10-01 / J. Immunother. 2015 Oct;38(8):330-9Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2015-09-29 / Oncotarget 2015 Sep;6(29):27751-62A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2015-09-15 / Oncotarget 2015 Sep;6(27):23462-79Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2015-09-11 / Oncoimmunology 2016 Feb;5(2):e1083669A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination
/in Dendritic Cells, Exosome, International Publications /von 2015-09-10 / Bioimpacts 2015;5(3):117-22Immunotherapy of Brain Tumors
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2015-09-04 / Prog Tumor Res 2015;42:11-21Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2015-09-01 / PLoS ONE 2015;10(9):e0136911Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2015-08-27 / J. Neurooncol. 2015 Oct;125(1):65-74
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de